{"disease":{"id":"coronavirus","name":"coronavirus"},"drugs":{"marketed":[{"drug_id":"remdesivir","indication_name":"Disease caused by Severe acute respiratory syndrome coronavirus 2","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Veklury","generic_name":"remdesivir","company_name":"Gilead Sciences","drug_phase":"marketed","molecular_target":"SARS-CoV-2 RNA polymerase","drug_class":"Nucleotide analog RNA polymerase inhibitor","quality_score":79,"revenue":"2200","mechanism":"Remdesivir is an antiviral nucleotide analog RNA polymerase inhibitor with activity against SARS-CoV-2."},{"drug_id":"baricitinib","indication_name":"Pneumonia caused by Severe acute respiratory syndrome coronavirus 2","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Olumiant","generic_name":"baricitinib","company_name":"Eli Lilly","drug_phase":"marketed","molecular_target":"Tyrosine-protein kinase JAK2","drug_class":"Janus Kinase Inhibitor [EPC]","quality_score":50,"revenue":"1200","mechanism":""},{"drug_id":"ensitrelvir","indication_name":"Disease caused by Severe acute respiratory syndrome coronavirus 2","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xocova","generic_name":"ENSITRELVIR","company_name":"Shionogi & Co., Ltd.","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":24,"revenue":"400","mechanism":""},{"drug_id":"tocilizumab","indication_name":"Pneumonia caused by Severe acute respiratory syndrome coronavirus 2","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Roactemra","generic_name":"tocilizumab","company_name":"Roche","drug_phase":"marketed","molecular_target":"Interleukin-6 receptor","drug_class":"Interleukin-6 Receptor Antagonist [EPC]","quality_score":10,"revenue":null,"mechanism":"Roactemra works by blocking the interleukin-6 receptor, a protein that plays a key role in inflammation."},{"drug_id":"veklury","indication_name":"Disease caused by Severe acute respiratory syndrome coronavirus 2","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Veklury","company_name":"ANRS, Emerging Infectious Diseases","drug_phase":"marketed","molecular_target":"NS5, Replicase polyprotein 1ab","drug_class":"Nucleoside analog prodrug","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"tocilizumab","indication_name":"Coronavirus Disease 2019 (COVID-19)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Roactemra","generic_name":"tocilizumab","company_name":"Roche","drug_phase":"marketed","molecular_target":"Interleukin-6 receptor","drug_class":"Interleukin-6 Receptor Antagonist [EPC]","quality_score":10,"revenue":null,"mechanism":"Roactemra works by blocking the interleukin-6 receptor, a protein that plays a key role in inflammation."},{"drug_id":"olumiant","indication_name":"Pneumonia caused by Severe acute respiratory syndrome coronavirus 2","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Olumiant","company_name":"NHS Greater Glasgow and Clyde","drug_phase":"marketed","molecular_target":"Casein kinase I isoform gamma-1, Citron Rho-interacting kinase, Mitogen-activated protein kinase kinase kinase 1","drug_class":"","quality_score":16,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":7,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04322786","title":"The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective?","phase":"","overall_status":"UNKNOWN","enrollment_count":1302508,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT04320732","title":"Risk Factors for Community- and Workplace Transmission of COVID-19","phase":"","overall_status":"RECRUITING","enrollment_count":250000,"lead_sponsor_name":"Oslo University Hospital","has_results":false},{"nct_id":"NCT03944447","title":"Outcomes Mandate National Integration With Cannabis as Medicine","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":200000,"lead_sponsor_name":"OMNI Medical Services, LLC","has_results":false},{"nct_id":"NCT07072793","title":"A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming Severe","phase":"","overall_status":"COMPLETED","enrollment_count":131005,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT04351503","title":"A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":126586,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT04323787","title":"Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry","phase":"","overall_status":"COMPLETED","enrollment_count":100000,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT05047900","title":"The Impact of SARS-CoV-2 Rapid Antigen Testing Kit Screening in Bangkok Community","phase":"NA","overall_status":"COMPLETED","enrollment_count":70000,"lead_sponsor_name":"Mahidol University","has_results":false},{"nct_id":"NCT05615792","title":"Observational Cohort of COVID-19 Patients in Hubei Province","phase":"","overall_status":"COMPLETED","enrollment_count":68000,"lead_sponsor_name":"Dao Wen Wang","has_results":false},{"nct_id":"NCT04342884","title":"COVID-19 Community Research Partnership","phase":"","overall_status":"COMPLETED","enrollment_count":61410,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":false},{"nct_id":"NCT04475484","title":"Online Survey on Psychological Impact of COVID-19 Epidemic on School-age Children","phase":"","overall_status":"UNKNOWN","enrollment_count":30000,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT04624048","title":"Exercise Influence on COVID-19","phase":"","overall_status":"UNKNOWN","enrollment_count":30000,"lead_sponsor_name":"University of Salamanca","has_results":false},{"nct_id":"NCT05407142","title":"An Open Comprative Study of the Prophylactic Efficacy and a Non-comparative Study of the Immunogenicity and Safety of the Inactivated Whole-virion Concentrated Purified Coronavirus Vaccine (CoviVac)","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":29000,"lead_sponsor_name":"Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products","has_results":false},{"nct_id":"NCT04715607","title":"COVID-19: SARS-CoV-2 Detection in Saliva, Oropharyngeal and Nasopharyngeal Specimens","phase":"NA","overall_status":"COMPLETED","enrollment_count":27947,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT04349202","title":"Beaumont Health Large-scale Automated Serologic Testing for COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":20614,"lead_sponsor_name":"Corewell Health East","has_results":false},{"nct_id":"NCT05726084","title":"Immunogenicity, Efficacy and Safety Trial of the Convacell Vaccine in Healthy Volunteers Aged 18 Years and Older","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":16304,"lead_sponsor_name":"St. Petersburg Research Institute of Vaccines and Sera","has_results":false},{"nct_id":"NCT04371419","title":"COVID-19 Health Messaging to Underserved Communities","phase":"NA","overall_status":"COMPLETED","enrollment_count":14267,"lead_sponsor_name":"National Bureau of Economic Research, Inc.","has_results":true},{"nct_id":"NCT04926571","title":"Dexamethasone and COVID-19 Inpatient Mortality","phase":"","overall_status":"COMPLETED","enrollment_count":14105,"lead_sponsor_name":"Aetion, Inc.","has_results":false},{"nct_id":"NCT04370067","title":"HUNgarian COronaVirus Disease-19 Epidemiological Research","phase":"","overall_status":"UNKNOWN","enrollment_count":11200,"lead_sponsor_name":"Semmelweis University Heart and Vascular Center","has_results":false},{"nct_id":"NCT04400838","title":"Investigating a Vaccine Against COVID-19","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":10811,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT04420286","title":"Study of the Increase in ICU Beds Capacity During COVID-19 Pandemic in France","phase":"","overall_status":"COMPLETED","enrollment_count":9860,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nīmes","has_results":false},{"nct_id":"NCT04416308","title":"COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB)","phase":"NA","overall_status":"COMPLETED","enrollment_count":9453,"lead_sponsor_name":"Rennes University Hospital","has_results":false},{"nct_id":"NCT04979208","title":"Impact of Changes in the Use of Care and Reorganization of the Healthcare System Linked to the Covid-19 Outbreak on the Quality of Care Pathways of Patients Suffering From Acute Myocardial Infarction and Stroke in Aquitaine (AVICOVID)","phase":"","overall_status":"COMPLETED","enrollment_count":9218,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT04320862","title":"COVID-19 Pandemic Response Network","phase":"","overall_status":"COMPLETED","enrollment_count":9207,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT04941144","title":"Long-Term Follow-up Survey of COVID-19 Vaccine After Vaccination","phase":"","overall_status":"COMPLETED","enrollment_count":8538,"lead_sponsor_name":"ModernaTX, Inc.","has_results":false},{"nct_id":"NCT04408170","title":"Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19)","phase":"","overall_status":"COMPLETED","enrollment_count":8380,"lead_sponsor_name":"Manchester University NHS Foundation Trust","has_results":false},{"nct_id":"NCT04727424","title":"Repurposed Approved and Under Development Therapies for Patients With Early-Onset COVID-19 and Mild Symptoms","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":7819,"lead_sponsor_name":"Cardresearch","has_results":false},{"nct_id":"NCT05097677","title":"Follow-up of Covid-19 Long Term Sequelae","phase":"","overall_status":"COMPLETED","enrollment_count":7599,"lead_sponsor_name":"Azienda Ospedaliera Universitaria Integrata Verona","has_results":false},{"nct_id":"NCT04542915","title":"COVID-19-Related Health and Practices Among Dental Hygienists","phase":"","overall_status":"COMPLETED","enrollment_count":6976,"lead_sponsor_name":"American Dental Association","has_results":false},{"nct_id":"NCT04385238","title":"Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic","phase":"","overall_status":"COMPLETED","enrollment_count":6894,"lead_sponsor_name":"Pregistry","has_results":true},{"nct_id":"NCT04327206","title":"BCG Vaccination to Protect Healthcare Workers Against COVID-19","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":6828,"lead_sponsor_name":"Murdoch Childrens Research Institute","has_results":false},{"nct_id":"NCT04324463","title":"Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":6667,"lead_sponsor_name":"Population Health Research Institute","has_results":false},{"nct_id":"NCT04367740","title":"ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":6313,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT04610515","title":"Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE)","phase":"","overall_status":"COMPLETED","enrollment_count":6000,"lead_sponsor_name":"Rush University Medical Center","has_results":false},{"nct_id":"NCT04318366","title":"COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor","phase":"","overall_status":"RECRUITING","enrollment_count":6000,"lead_sponsor_name":"Università Vita-Salute San Raffaele","has_results":false},{"nct_id":"NCT05244356","title":"Health Communication to Influence COVID-19 Vaccination Intent and Message Propagation","phase":"NA","overall_status":"COMPLETED","enrollment_count":5784,"lead_sponsor_name":"Clinical Research Centre, Malaysia","has_results":false},{"nct_id":"NCT04359849","title":"Sequencing and Tracking of Phylogeny in COVID-19 Study","phase":"","overall_status":"COMPLETED","enrollment_count":5602,"lead_sponsor_name":"Portsmouth Hospitals NHS Trust","has_results":false},{"nct_id":"NCT04375761","title":"COVID-19: Human Epidemiology and Response to SARS-CoV-2","phase":"","overall_status":"COMPLETED","enrollment_count":5599,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT04324736","title":"\"COVID-19 and Diabetes Outcomes\"","phase":"","overall_status":"COMPLETED","enrollment_count":5309,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT04343898","title":"Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":5154,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT04545047","title":"Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":5044,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT05458557","title":"Antigen Rapid Diagnostic Tests for Community Identification of Severe Acute Respiratory Syndrome Coronavirus 2","phase":"","overall_status":"COMPLETED","enrollment_count":5000,"lead_sponsor_name":"Elizabeth Glaser Pediatric AIDS Foundation","has_results":false},{"nct_id":"NCT04321811","title":"Behavior, Environment And Treatments for Covid-19","phase":"","overall_status":"COMPLETED","enrollment_count":5000,"lead_sponsor_name":"xCures","has_results":false},{"nct_id":"NCT05569408","title":"eVusheld Assessment reaL wORld Effectiveness in DoD Health System","phase":"","overall_status":"COMPLETED","enrollment_count":4724,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT04303507","title":"Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting","phase":"NA","overall_status":"COMPLETED","enrollment_count":4652,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT04262921","title":"French COVID Cohort","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":4415,"lead_sponsor_name":"Institut National de la Santé Et de la Recherche Médicale, France","has_results":false},{"nct_id":"NCT05354024","title":"Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":4400,"lead_sponsor_name":"Butantan Institute","has_results":false},{"nct_id":"NCT05543616","title":"A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":4292,"lead_sponsor_name":"BioNTech SE","has_results":false},{"nct_id":"NCT05594147","title":"An Observational Study, Called ROCURS, to Learn About COVID-19 Related Outcomes in People With Cancer Who Are Treated With Tyrosine Kinase Inhibitors (TKIs) Including Regorafenib or Sorafenib","phase":"","overall_status":"COMPLETED","enrollment_count":4103,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04518410","title":"ACTIV-2: A Study for Outpatients With COVID-19","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":4044,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT04348214","title":"Screening & Risk Assessment of Healthcare Workers & Infection Control in University & COVID-19 Quarantine Hospitals","phase":"","overall_status":"COMPLETED","enrollment_count":4040,"lead_sponsor_name":"Ain Shams University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}